These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 1472466)
1. Interaction of two cytoplasmic erythroid differentiation-inducing factors in mouse erythroleukemia cells. Watanabe T; Oishi M Cell Growth Differ; 1992 Dec; 3(12):865-71. PubMed ID: 1472466 [TBL] [Abstract][Full Text] [Related]
2. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response. Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239 [TBL] [Abstract][Full Text] [Related]
3. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Watanabe T; Kondo K; Oishi M Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116 [TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells. Watanabe T; Oishi M Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6481-5. PubMed ID: 3476957 [TBL] [Abstract][Full Text] [Related]
5. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells. Yamashita T; Eto Y; Shibai H; Ogata E Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914 [TBL] [Abstract][Full Text] [Related]
7. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L Cancer Res; 1998 Nov; 58(22):5057-60. PubMed ID: 9823310 [TBL] [Abstract][Full Text] [Related]
8. [Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells]. Zhao Q; Ge YH; Zhou JP; Ma J; Chen KQ; Xue SP; Han DS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):32-5. PubMed ID: 12905814 [TBL] [Abstract][Full Text] [Related]
9. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
10. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1. Choe KS; Radparvar F; Matushansky I; Rekhtman N; Han X; Skoultchi AI Cancer Res; 2003 Oct; 63(19):6363-9. PubMed ID: 14559825 [TBL] [Abstract][Full Text] [Related]
11. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells. Mitsuse S; Oishi M Cancer Res; 1985 Aug; 45(8):3836-42. PubMed ID: 3860288 [TBL] [Abstract][Full Text] [Related]
12. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908 [TBL] [Abstract][Full Text] [Related]
13. Specific erythroid differentiation of mouse erythroleukemia cells by activins and its enhancement by retinoic acids. Uchiyama H; Asashima M Biochem Biophys Res Commun; 1992 Aug; 187(1):347-52. PubMed ID: 1520319 [TBL] [Abstract][Full Text] [Related]